|Podcasts|December 25, 2022

AJMC® Editors Reflect and Look Forward to 2023

The editors of The American Journal of Managed Care® reflect on the past year and discuss what they’re looking forward to in 2023.

On this episode of Managed Care Cast, we’re talking with the co–editors in chief of The American Journal of Managed Care^®, Mark Fendrick, MD, and Michael Chernew, PhD. They look back on the past year and discuss what they’re looking forward to in 2023.

iTunes
TuneIn
Stitcher
Spotify

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Trulicity | Image credit: omar - stock.adobe.com

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC® Editors Reflect and Look Forward to 2023

Newsletter

Related Content

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

New Dermatologic Therapies Make Waves at Maui Derm 2026

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

FDA Greenlights D-VRd Quadruplet for Newly Diagnosed Multiple Myeloma